Quadria-Backed Aragen Life Said to Plan $300 Million India IPO

Aragen Life Sciences, backed by private equity firm Quadria Capital, is planning to launch an initial public offering (IPO) in India with a target size of $300 million. The company is a laboratory and life sciences organization preparing to go public in the Indian market.